Bill Anderson
Former colleagues view Anderson as a solid choice but caution his relaxed management style may limit short-term impact amid Germany’s conservative corporate environment.
Although undecided on an activist-suggested Bayer breakup, Anderson likely sees value in the proposal.
Sources uniformly praise his expertise, leadership, management approach, and proven track record of delivering results at Genentech and Roche.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.